In conclusion, our data demonstrated that mRNA expression levels of ERCC1 and TS were not significantly correlated with the DFS of Chinese stage II-III CRC patients receiving 5-FU and oxaliplatin based adjuvant chemotherapy. This evidence concerns the gene ERCC1 and colorectal carcinoma.